# Nika Pharmaceuticals Inc. (NIKA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NIKA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -33.1K | $ -21.0K | N/A | $ -330.7K |
| 2025 | $ 0 | $ -78.2K | $ -81.6K | N/A | $ -297.6K |
| 2024 | $ 0 | $ -148.8K | $ -146.2K | $ 239.2K | $ -221.2K |
| 2023 | $ 0 | $ -7.9K | $ -7.9K | $ 101.7K | $ -82.1K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Liabilities / Eq | -1.03 |
| Current Ratio | 0.03 |

## Other views

- [Metrics](https://sponda.capital/en/NIKA.md)
- [Charts](https://sponda.capital/en/NIKA/charts.md)
- [Compare](https://sponda.capital/en/NIKA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.